Muhammad Bilal Abid

32PUBLICATIONS
165CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 27, 2026
Infectious Complications and Toxicities of the Teclistamab Plus Daratumumab Combination in Relapsed or Refractory Multiple Myeloma: A Disproportionality and Drug-Interaction Analysis of the FDA Adverse Event Reporting System.

|Oct 16, 2026
Non-Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis.

|Sep 24, 2026
Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article.

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|May 11, 2026
Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings.

|Jul 22, 2025
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.

Nasheed M Hossain, Kwang Woo Ahn, Jinalben Patel

Pageof 6

Frequent Collaborators

5 joint publications

Akshay Sharma

4 joint publications

Mohamed Kharfan-Dabaja

3 joint publications

Sachiko Seo

3 joint publications

Daniel Weisdorf